1.
Sanchorawala V, Quillen K, Sloan JM, Andrea NT, Seldin DC. Bortezomib and high-dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study. Haematologica [Internet]. 2011Dec.6 [cited 2026Nov.16];96(12):1890-2. Available from: https://haematologica.org/article/view/6168